Contact Us How Can We Help
Check supplier reputation in peptide research forums
Currently, pegvisomant is the only clinically used GHR inhibitor
A total of 12 events were reported in five participants (35.7%) in the normal hepatic function group, three events in three participants (42.9%) in the mild hepatic impairment group and one event in one participant (14.3%) in the moderate hepatic impairment group
However, some may experience mild, temporary irritation, redness, or even minor breakoutsoften referred to as 'copper peptide uglies'especially when first starting or using higher concentrations
The peptides used in supervised settings are studied for helping soft tissue heal, supporting connective tissue, easing recovery between hard sessions, and in some cases supporting body composition and sleep quality